- Email: [email protected]
Seprotech releases third quarter results
News & Views purification products is in the region of US$30 million per year. For further information contact: Pall Corporation, 2200 Northern Boulevard, East Hills, NY 11548-1289, USA. Tel: +1 516 484 5400;fax: +1 516 484 3529.
Commodore to access
Far East
through joint venture In a transaction that promises early access to Far Eastern markets for its environmental and industrial technologies, Commodore Applied Technologies, Inc. has entered into a business agreement with Hong Kongbased Allied Pacific Group Limited. The joint venture will commercialize Commodore's proprietary technologies, the solvated electron technology (SET) process and the supported liquid m e m b r a n e (SLM) separation process, principally in Taiwan and the Pacific Rim. The SLM technological process, owned by Commodore's publicly traded subsidiary, Commodore Separation Technologies, can separate m a n y materials dissolved in either a liquid or gaseous feedstream and is expected to have wide application in most industries such as metal plating, environmental cleanup, pharmaceutical and mining. Commodore also revealed that it's patent pending SLM process holds an exclusive worldwide license from Lockheed Martin, m a n a g e r of the US Department of Energy's Oak Ridge National Laboratory, to use and develop the technology for separating technetium and r h e n i u m from mixed wastes in nuclear wastewater. For further information contact: Commodore Applied Technologies, Inc., 150 E. 58th St, Ste. 3400 N e w York, NY 10155, USA. Tel: +1 212 308 5800; fcvc +1 212 753 0731.
million in the same period one year ago. Net earnings however, were down to US$1.03 million compared with US$1.29 million in the first quarter last year. President and CEO T h o m a s J. McGoldrick was reported to be "very encouraged" by the Company's first quarter results considering the significant changes during the Company's recent restructuring. McGoldrick commented that: "Our dialysis reprocessing business continued to achieve steady sales growth. First quarter revenues reflect record domestic sales of Renatron II dialyser reprocessing stations. In addition, Minntech B.V., our European subsidiary, had an outstanding quarter, largely due to above-forecast sales of Minntech's new high performance oxygenator - - the Biocor 200." For further information contact: Minntech Corporation, 14605 - 28th A v e n u e North, Minneapolis, MN 55447, USA. Tel: +I 612 553 3300;fax: +1 612 553 3387.
Seprotech releases third quarter results Seprotech Systems Incorporated the Canadian specialist in crossflow m e m b r a n e technology, has a n n o u n c e d revenues of C$2.9 million for the third quarter ended 31 May 1997. The reported revenue is the same figure as was reported for the same period last year. Seprotech report that the cost of sales relative to revenue, is now starting to reflect the improved profitability on current business activity. Operating expenses were down C$0.6 million to C$1.2 million, compared with C$1.8 million for the same period the previous year. The operating loss for the period was C$0.97 million compared with C$1.2million for the same period the prior year. The Company reported a net loss for the first nine m o n t h s of this fiscal year of C$1.6 million ($0.33 per common share), compared to a loss of C$1.2 million ($0.25 per c o m m o n share) for the same period the prior year.
Minntech
For further information contact: Seprotech S y s t e m s Inc., 2378 Holly Lane, Ottawa, Ontario, Canada K I V 7P1. Tel: +1 613 523 1641;fax: +1 613 731 0851. e-mail: [email protected]
restructuring gives record first
CuUigan acquires
quarter sales Minneapolis based Minntech Corporation, specialists in medical filtration products, recently a n n o u n c e d that after a restructuring programme, total revenues for the first quarter ended J u n e 30, 1997, were US$17.75 million, up 6.4 percent from revenues of US$16.68
4
Ametek water filtration arm Culligan Water Technologies, Inc. of Illinois, USA, has a n n o u n c e d that it has completed the acquisition of the
M e m b r a n e T e c h n o l o g y No. 8 8
Commodore to access
Far East
through joint venture In a transaction that promises early access to Far Eastern markets for its environmental and industrial technologies, Commodore Applied Technologies, Inc. has entered into a business agreement with Hong Kongbased Allied Pacific Group Limited. The joint venture will commercialize Commodore's proprietary technologies, the solvated electron technology (SET) process and the supported liquid m e m b r a n e (SLM) separation process, principally in Taiwan and the Pacific Rim. The SLM technological process, owned by Commodore's publicly traded subsidiary, Commodore Separation Technologies, can separate m a n y materials dissolved in either a liquid or gaseous feedstream and is expected to have wide application in most industries such as metal plating, environmental cleanup, pharmaceutical and mining. Commodore also revealed that it's patent pending SLM process holds an exclusive worldwide license from Lockheed Martin, m a n a g e r of the US Department of Energy's Oak Ridge National Laboratory, to use and develop the technology for separating technetium and r h e n i u m from mixed wastes in nuclear wastewater. For further information contact: Commodore Applied Technologies, Inc., 150 E. 58th St, Ste. 3400 N e w York, NY 10155, USA. Tel: +1 212 308 5800; fcvc +1 212 753 0731.
million in the same period one year ago. Net earnings however, were down to US$1.03 million compared with US$1.29 million in the first quarter last year. President and CEO T h o m a s J. McGoldrick was reported to be "very encouraged" by the Company's first quarter results considering the significant changes during the Company's recent restructuring. McGoldrick commented that: "Our dialysis reprocessing business continued to achieve steady sales growth. First quarter revenues reflect record domestic sales of Renatron II dialyser reprocessing stations. In addition, Minntech B.V., our European subsidiary, had an outstanding quarter, largely due to above-forecast sales of Minntech's new high performance oxygenator - - the Biocor 200." For further information contact: Minntech Corporation, 14605 - 28th A v e n u e North, Minneapolis, MN 55447, USA. Tel: +I 612 553 3300;fax: +1 612 553 3387.
Seprotech releases third quarter results Seprotech Systems Incorporated the Canadian specialist in crossflow m e m b r a n e technology, has a n n o u n c e d revenues of C$2.9 million for the third quarter ended 31 May 1997. The reported revenue is the same figure as was reported for the same period last year. Seprotech report that the cost of sales relative to revenue, is now starting to reflect the improved profitability on current business activity. Operating expenses were down C$0.6 million to C$1.2 million, compared with C$1.8 million for the same period the previous year. The operating loss for the period was C$0.97 million compared with C$1.2million for the same period the prior year. The Company reported a net loss for the first nine m o n t h s of this fiscal year of C$1.6 million ($0.33 per common share), compared to a loss of C$1.2 million ($0.25 per c o m m o n share) for the same period the prior year.
Minntech
For further information contact: Seprotech S y s t e m s Inc., 2378 Holly Lane, Ottawa, Ontario, Canada K I V 7P1. Tel: +1 613 523 1641;fax: +1 613 731 0851. e-mail: [email protected]
restructuring gives record first
CuUigan acquires
quarter sales Minneapolis based Minntech Corporation, specialists in medical filtration products, recently a n n o u n c e d that after a restructuring programme, total revenues for the first quarter ended J u n e 30, 1997, were US$17.75 million, up 6.4 percent from revenues of US$16.68
4
Ametek water filtration arm Culligan Water Technologies, Inc. of Illinois, USA, has a n n o u n c e d that it has completed the acquisition of the
M e m b r a n e T e c h n o l o g y No. 8 8